![Jacob van Naarden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacob van Naarden
Directeur Général chez
LOXO ONCOLOGY INC
Fortune : 40 M $ au 31/05/2026
Profil
Mr. Jacob S.
van Naarden is a President-Lilly Oncology & Executive VP at Eli Lilly & Co. and a Chief Executive Officer at Loxo Oncology, Inc. He is on the Board of Directors at Delfi Diagnostics, Inc. Mr. van Naarden was previously employed as an Analyst by HealthCor Management LP, an Associate by Aisling Capital LLC, and an Analyst by Goldman Sachs & Co. He received his undergraduate degree from Princeton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/02/2026 | 36 270 ( 0% ) | 40 M $ | 31/05/2026 |
Postes actifs de Jacob van Naarden
| Sociétés | Poste | Début |
|---|---|---|
| LOXO ONCOLOGY INC | Directeur Général | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2024 |
Delfi Diagnostics, Inc.
 Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Directeur/Membre du Conseil | 22/06/2022 |
Anciens postes connus de Jacob van Naarden
| Sociétés | Poste | Fin |
|---|---|---|
HealthCor Management LP
 HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Analyst-Equity | 01/05/2014 |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Analyste en capital-investissement | 01/01/2013 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Formation de Jacob van Naarden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Finance |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Health Services |
